United States· US:55289-493_419aeba7-0cd0-2a17-e063-6394a90a2279

Docusate Sodium

A natriumdocusat, inkl. kombinationen product containing docusate sodium, registered in United States by PD-Rx Pharmaceuticals, Inc.. The same ATC class is registered in 8 of our 19 countries.

ATC A06AG10US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDocusate SodiumATCA06AG10REGISTER NO.US:55289-493_419aeba7…PACKS LISTED7CHECKEDSeptember 12, 2026

Where it is registered

Natriumdocusat, inkl. kombinationen is registered in 8 of 19 countries.

Countries holding a registration under ATC A06AG10 (natriumdocusat, inkl. kombinationen), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 5 of them publish a price we can compare per daily dose

Natriumdocusat, inkl. kombinationen · ATC A06AG10

8 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Icelandprice
  • Netherlands
  • Norwayprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
Docusate Sodium
Manufacturer
PD-Rx Pharmaceuticals, Inc.
Country
United States (US)
ATC code
A06AG10
ATC class
Natriumdocusat, inkl. Kombinationen
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 12, 2026

Packs & prices · 7

  • ndc11
    5528949301
    100 CAPSULE in 1 BOTTLE, PLASTIC (55289-493-01)
  • ndc11
    5528949312
    12 CAPSULE in 1 BOTTLE, PLASTIC (55289-493-12)
  • ndc11
    5528949314
    14 CAPSULE in 1 BOTTLE, PLASTIC (55289-493-14)
  • ndc11
    5528949330
    30 CAPSULE in 1 BOTTLE, PLASTIC (55289-493-30)
  • ndc11
    5528949360
    60 CAPSULE in 1 BOTTLE, PLASTIC (55289-493-60)
  • ndc11
    5528949390
    90 CAPSULE in 1 BOTTLE, PLASTIC (55289-493-90)
  • ndc11
    5528949393
    180 CAPSULE in 1 BOTTLE, PLASTIC (55289-493-93)

Regulatory notes

UNII (FDA substance ID)
F05Q2T2JA0
DOCUSATE SODIUM
RxCUI 71722
DailyMed SPL labels
1 version tracked

Same medicine, other countries

Natriumdocusat, inkl. kombinationen in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All natriumdocusat, inkl. kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Belgium · Norgalax
  • France · Jamylene, Norgalax
  • United Kingdom (Northern Ireland) · Dioctyl, Docusate Sodium Adult Typharm
  • Ireland · Waxsol
  • Luxembourg · Norgalax
  • Netherlands · Norgalax
  • Poland · Laxol, Ulgix Laxi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/66ffb155-aa18-42b6-a4ea-bead4587a71f
GET /v1/drugs/66ffb155-aa18-42b6-a4ea-bead4587a71f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "F05Q2T2JA0",
    "rxcui": "71722",
    "inchikey": "APSBXTVYXVQYAB-UHFFFAOYSA-M",
    "display_name": "DOCUSATE SODIUM",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 5
  },
  "spl_meta": {
    "492b6d37-47cf-3a28-e063-6294a90a2a18": {
      "match": "brand_token",
      "title": "DOCUSATE SODIUM LIQUID (DOCUSATE SODIUM.50MG/5ML) SOLUTION [ALDAMA PHARMACEUTICALS, INC]",
      "spl_version": "2",
      "published_date": "2026-06-02"
    }
  },
  "productid": "55289-493_419aeba7-0cd0-2a17-e063-6394a90a2279",
  "productndc": "55289-493",
  "dosage_form": "CAPSULE",
  "dea_schedule": null,
  "product_type": "HUMAN OTC DRUG",
  "substance_name": "DOCUSATE SODIUM",
  "proprietary_name": "Docusate Sodium",
  "active_ingred_unit": "mg/1",
  "application_number": "M007",
  "marketing_category": "OTC MONOGRAPH DRUG",
  "nonproprietary_name": "Docusate Sodium",
  "start_marketing_date": "20160301",
  "active_numerator_strength": "100"
}

See everything about natriumdocusat, inkl. kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.